AUSTIN SINGHAVONG: Open Payments
NPI 1073188207 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$410 in 15 payments from 10 companies in 2025. Trend: 2023 $977 · 2024 $131 · 2025 $410
Food & beverage: $410
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 1 | $92 |
| Olympus America Inc. | 3 | $68 |
| Pacira Pharmaceuticals Incorporated | 2 | $52 |
| Innovation Technologies Inc | 3 | $46 |
| Boston Scientific Corporation | 1 | $39 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $33 |
| Globus Medical, Inc. | 1 | $25 |
| Fidia Pharma USA Inc. | 1 | $22 |
| Endo USA, Inc. | 1 | $17 |
| CONMED Corporation | 1 | $16 |
Products named: ETERNA, iTIND System, IRRISEPT, Intracept, JOURNAVX, Zilretta, EXCELSIUS GPS, Exparel.
Industry payments across CA — which companies pay providers there.
